Literature DB >> 19435969

Gout and quality of life.

Seo Young Kim, Hyon K Choi.   

Abstract

Mesh：

Year:  2009        PMID： 19435969     DOI： 10.3899/jrheum.090034

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  7 in total

1.  Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer?

Authors:  Tuhina Neogi
Journal:  Arthritis Rheum       Date:  2010-10

2.  Minimally important differences of the gout impact scale in a randomized controlled trial.

Authors:  Dinesh Khanna; Andrew J Sarkin; Puja P Khanna; Marian M Shieh; Arthur F Kavanaugh; Robert A Terkeltaub; Susan J Lee; Jasvinder A Singh; Jan D Hirsch
Journal:  Rheumatology (Oxford)       Date:  2011-03-03       Impact factor: 7.580

Review 3.  Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.

Authors:  Nicola Dalbeth; Hyon K Choi; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

Review 4.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

5.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

6.  Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR).

Authors:  Carlo A Scire; Maria Manara; Marco A Cimmino; Marcello Govoni; Fausto Salaffi; Leonardo Punzi; Maria C Monti; Greta Carrara; Carlomaurizio Montecucco; Marco Matucci-Cerinic; Giovanni Minisola
Journal:  Arthritis Res Ther       Date:  2013-08-23       Impact factor: 5.156

7.  What Outcomes are Important for Gout Patients? In-Depth Qualitative Research into the Gout Patient Experience to Determine Optimal Endpoints for Evaluating Therapeutic Interventions.

Authors:  Sophi Tatlock; Katja Rüdell; Charlotte Panter; Rob Arbuckle; Leslie R Harrold; William J Taylor; Tara Symonds
Journal:  Patient       Date:  2017-02       Impact factor: 3.883
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.